Rocky Mountain Cancer Center

Colorado Springs, Colorado 80909

2 studies enrolling now · 6 studies all time

What they study most

Cancer, Castration-Resistant Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), MPN (Myeloproliferative Neoplasms), Metastatic Prostate Cancer, Neoplasms, Non-small Cell Lung Cancer, Prostate Cancer, Prostate Cancer (Adenocarcinoma)

Studies at this site

• Study of Oral MRT-2359 With Apalutamide in Prostate Cancer — Recruiting now
• Study of ORIC-944 in Patients With Metastatic Prostate Cancer — Recruiting now
• The Circulating Cell-free Genome Atlas Study — Status unconfirmed
• A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early